New eye device tested to fight glaucoma when drops fail

NCT ID NCT07358650

Summary

This is the first study in people to test the safety and performance of a new medical device called MIST. It aims to lower high eye pressure in adults with a common type of glaucoma that isn't well controlled by prescription eye drops. Doctors will perform a minor procedure with the device and follow patients for one year to see how well it works and check for any side effects.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY OPEN ANGLE GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Eye Care Centre NB

    RECRUITING

    Dieppe, New Brunswick, E1A 9T8, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Institut de l'oeil des Laurentides

    RECRUITING

    Boisbriand, Quebec, J7H 0E8, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Miramichi EyeNB & Surgical Centres of Excellence

    RECRUITING

    Miramichi, New Brunswick, E1N 1B2, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Ophthalmology Clinic Bellevue

    RECRUITING

    Montreal, Quebec, H1V 1G5, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Prism Eye Institute Inc.

    RECRUITING

    Brampton, Ontario, L6Y 4M3, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.